Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle A Kelliher

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 24, 2018
Analyzing Necroptosis Using an RIPK1 Kinase Inactive Mouse Model of TNF ShockMatija Zelic, Michelle A Kelliher
Frontiers in Immunology|April 11, 2019
NOTCH Signaling in T-Cell-Mediated Anti-Tumor Immunity and T-Cell-Based ImmunotherapiesMichelle A Kelliher, Justine E Roderick
Blood|January 12, 2019
BID-ding on necroptosis in MDSBen A Croker, Michelle A Kelliher
Trends in Immunology|February 5, 2023
TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapyMichelle A Kelliher, Katherine A Fitzgerald
Cancer Cell|March 22, 2014
Leukemia propagating cells Akt upAlejandro Gutierrez, Justine E Roderick, Michelle A Kelliher
Cell Cycle (Georgetown, Tex.)|April 4, 2007
The Notch1/c-Myc pathway in T cell leukemiaVishva Mitra Sharma, Kyle M Draheim, Michelle A Kelliher
Cancer Research|June 17, 2006
NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cellsPei-Yun Chang, Kyle Draheim, Michelle A Kelliher, et al.
Breast Cancer Research : BCR|September 21, 2012
NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitroMatthew J Simmons, Ryan Serra, Nicole Hermance, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
High-Throughput Screening of Tyrosine Kinase Inhibitor Resistant Genes in CMLLeyuan Ma, Justine Roderick, Michelle A Kelliher, et al.
The Journal of Biological Chemistry|June 4, 2004
The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2Thomas H Lee, Jennifer Shank, Nicole Cusson, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|August 24, 2018
Analyzing Necroptosis Using an RIPK1 Kinase Inactive Mouse Model of TNF ShockMatija Zelic, Michelle A Kelliher
Frontiers in Immunology|April 11, 2019
NOTCH Signaling in T-Cell-Mediated Anti-Tumor Immunity and T-Cell-Based ImmunotherapiesMichelle A Kelliher, Justine E Roderick
Blood|January 12, 2019
BID-ding on necroptosis in MDSBen A Croker, Michelle A Kelliher
Trends in Immunology|February 5, 2023
TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapyMichelle A Kelliher, Katherine A Fitzgerald
Cancer Cell|March 22, 2014
Leukemia propagating cells Akt upAlejandro Gutierrez, Justine E Roderick, Michelle A Kelliher
Cell Cycle (Georgetown, Tex.)|April 4, 2007
The Notch1/c-Myc pathway in T cell leukemiaVishva Mitra Sharma, Kyle M Draheim, Michelle A Kelliher
Cancer Research|June 17, 2006
NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cellsPei-Yun Chang, Kyle Draheim, Michelle A Kelliher, et al.
Breast Cancer Research : BCR|September 21, 2012
NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitroMatthew J Simmons, Ryan Serra, Nicole Hermance, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
High-Throughput Screening of Tyrosine Kinase Inhibitor Resistant Genes in CMLLeyuan Ma, Justine Roderick, Michelle A Kelliher, et al.
The Journal of Biological Chemistry|June 4, 2004
The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2Thomas H Lee, Jennifer Shank, Nicole Cusson, et al.
Pageof 7